Yan Chuanzhu

[Expert Profile] Yan Chuanzhu, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in neuromuscular diseases in China, working in the Department of Neurology, Qilu Hospital of Shandong University. He has long been dedicated to the clinical diagnosis, treatment, and pathological research of muscular dystrophy, metabolic myopathy, mitochondrial encephalomyopathy, and other neuromuscular diseases, and is a discipline leader in neuromuscular disease studies in China.

[Education & Career] Professor Yan Chuanzhu graduated from Shandong Medical University, completed systematic training in the Department of Neurology at Qilu Hospital, and has long been engaged in neuromuscular disease and neuropathology research. He further studied at internationally renowned neuromuscular disease centers, systematically mastering muscle biopsy pathology, electrophysiology, and molecular diagnostic techniques. He has held important academic positions such as leader of the Neuromuscular Diseases Group of the Neurology Branch of the Chinese Medical Association, and has presided over multiple national-level projects including the National Natural Science Foundation of China, making important contributions to the discipline development of neurology at Qilu Hospital.

[Areas of Expertise] Professor Yan specializes in the diagnosis and treatment of various muscular dystrophies, inflammatory myopathies, metabolic myopathies, mitochondrial encephalomyopathies, and peripheral neuromuscular diseases. He has profound expertise in muscle biopsy pathological diagnosis, electromyography, and neuroelectrophysiology interpretation. He excels at identifying various "unexplained" cases of muscle weakness, muscle atrophy, and exercise intolerance through a precise diagnostic model combining pathology and genetics. He is proficient in the standardized application of novel therapies such as corticosteroids, immunosuppressants, and enzyme replacement therapy, providing clear etiologies and scientific treatment for numerous patients with rare neuromuscular diseases.

[Academic Achievements & Industry Contributions] Professor Yan has led the establishment of a domestically leading neuromuscular disease clinical and pathological diagnosis platform, systematically conducting research on the gene spectrum and pathological phenotypes of neuromuscular diseases in Chinese populations, and has discovered and reported multiple novel gene variants and disease subtypes, with research findings published in authoritative domestic and international neurology and pathology journals. He has actively promoted the establishment of a multidisciplinary collaborative diagnosis and treatment model for neuromuscular diseases, participated in the development of Chinese related disease diagnosis and treatment guidelines and expert consensus statements, and led clinical research on novel therapies such as enzyme replacement therapy, enabling many patients with neuromuscular rare diseases who were previously "untreatable" to receive standardized treatment, driving the overall progress of neuromuscular disease studies in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Yan has treated tens of thousands of difficult neuromuscular disease patients, many of whom have traveled from across the country and even overseas to seek his care. He is exceptionally meticulous with every muscle pathology slide, upholding the rigorous academic style of "pathology as the gold standard," and has provided clear diagnoses for numerous myopathy patients who were previously misdiagnosed. His students are distributed in neuromuscular disease specialties nationwide, and he has been invited to deliver special reports at national academic conferences on multiple occasions. He is an authoritative expert in the field of neuromuscular diseases, deeply respected by peers and trusted by patients.

[Honors & Reputation] Professor Yan Chuanzhu serves as Vice Chair of the Neurology Branch of the Chinese Medical Association and Chair of the Neurology Branch of the Shandong Medical Association, among other academic positions. He has presided over multiple national-level projects including key grants from the National Natural Science Foundation of China, and is an authoritative expert in the fields of myopathy and peripheral neuropathy in China. He has systematically established a domestically leading muscle pathology and neuropathology diagnostic platform, achieving domestically advanced standards in the precise diagnosis and treatment of difficult myopathies such as muscular dystrophy, metabolic myopathy, and mitochondrial encephalomyopathy. He has promoted the standardized application of genetic diagnostic techniques for rare myopathies, with research findings receiving multiple provincial and ministerial science and technology awards. He has trained a large number of neuromuscular disease specialists, helping numerous myopathy patients who were long misdiagnosed or missed receive clear diagnoses and standardized treatment, and is deeply trusted by patients.